These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25817964)

  • 1. Comparative study of modification of the osmolarity in graft versus host disease.
    García-Delpech S; Hervás Ontiveros A; Soler M; Udaondo P; Cisneros-Lanuza Á
    Arch Soc Esp Oftalmol; 2015 Aug; 90(8):401-2. PubMed ID: 25817964
    [No Abstract]   [Full Text] [Related]  

  • 2. Reflection on tears and treatments.
    Foulks GN
    Ocul Surf; 2008 Oct; 6(4):151. PubMed ID: 18827946
    [No Abstract]   [Full Text] [Related]  

  • 3. [Autologous serum tears: Long-term treatment in dry eye syndrome].
    Beylerian M; Lazaro M; Magalon J; Veran J; Darque A; Grimaud F; Stolowy N; Beylerian H; Sabatier F; Hoffart L
    J Fr Ophtalmol; 2018 Mar; 41(3):246-254. PubMed ID: 29602451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study.
    Tahmaz V; Gehlsen U; Sauerbier L; Holtick U; Engel L; Radojska S; Petrescu-Jipa VM; Scheid C; Hallek M; Gathof B; Cursiefen C; Steven P
    Br J Ophthalmol; 2017 Mar; 101(3):322-326. PubMed ID: 27267447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sjögren's Syndrome, Non-Sjögren's Syndrome, and Graft-Versus-Host Disease Related Dry Eye.
    Ogawa Y
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES71-DES79. PubMed ID: 30481809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hypotonic and isotonic solutions containing sodium hyaluronate on the symptomatic treatment of dry eye patients.
    Papa V; Aragona P; Russo S; Di Bella A; Russo P; Milazzo G
    Ophthalmologica; 2001; 215(2):124-7. PubMed ID: 11244343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osmolarity of prevalent eye drops, side effects, and therapeutic approaches.
    Dutescu RM; Panfil C; Schrage N
    Cornea; 2015 May; 34(5):560-6. PubMed ID: 25789693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry Eye.
    Clayton JA
    N Engl J Med; 2018 Jun; 378(23):2212-2223. PubMed ID: 29874529
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment and management of dry eye disease.
    Buckley RJ
    Eye (Lond); 2018 Feb; 32(2):200-203. PubMed ID: 29303149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
    Benelli U; Nardi M; Posarelli C; Albert TG
    Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for 24-hour management of dry eye disease: A review.
    Guillon M; Shah S
    Cont Lens Anterior Eye; 2019 Apr; 42(2):147-154. PubMed ID: 30497903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous artificial tears used for treatment of dry eye syndrome in patients with chronic graft versus host disease.
    Antoniewicz-Papis J; Lachert E; Janik K; Łętowska M
    Pol Arch Intern Med; 2017 Oct; 127(10):705-707. PubMed ID: 29162791
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of osmoprotective eye drops on tear osmolarity in contact lens wearers.
    Aslan Bayhan S; Bayhan HA; Muhafız E; Bekdemir Ş; Gürdal C
    Can J Ophthalmol; 2015 Aug; 50(4):283-9. PubMed ID: 26257222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Ogawa Y; Okamoto S; Mori T; Yamada M; Mashima Y; Watanabe R; Kuwana M; Tsubota K; Ikeda Y; Oguchi Y
    Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
    Lee HS; Ji YS; Yoon KC
    Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Chiang CC; Lin JM; Chen WL; Tsai YY
    Cornea; 2007 Aug; 26(7):861-3. PubMed ID: 17667623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tear osmolarity in ocular graft-versus-host disease.
    Berchicci L; Iuliano L; Miserocchi E; Bandello F; Modorati G
    Cornea; 2014 Dec; 33(12):1252-6. PubMed ID: 25343699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tear film thickness after treatment with artificial tears in patients with moderate dry eye disease.
    Schmidl D; Schmetterer L; Witkowska KJ; Unterhuber A; dos Santos VA; Kaya S; Nepp J; Baar C; Rosner P; Werkmeister RM; Garhofer G
    Cornea; 2015 Apr; 34(4):421-6. PubMed ID: 25651494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
    Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
    Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Dry Eye Therapies on Environmentally Induced Ocular Surface Disease.
    Moore QL; De Paiva CS; Pflugfelder SC
    Am J Ophthalmol; 2015 Jul; 160(1):135-42.e1. PubMed ID: 25868759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.